top of page

Weekly Drug News : January 23, 2019

With a U.S. government shutdown now extending into a second month, the FDA still manages to approve a third biosimilar for Herceptin known as Ontruzant. Plus, more recall updates are posted for the large class of blood pressure meds known as ARBs. Published studies look at other issues: aspirin use in healthy seniors, a new class of type 2 diabetes drug, and how treatment centers are addressing the ongoing opioid epidemic.


Recent Posts

See All


Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page